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Purpose: Delineating the precise localization of prostate cancer is important in improving the diagnostic accuracy of prostate biopsy.
Methods: In Juntendo University Nerima Hospital, initial 12-core or repeat 16-core biopsies were performed using a transrectal 
ultrasound guided transperineal prostate biopsy method. We step-sectioned prostates from radical prostatectomy specimens at 
5-mm intervals from the urethra to the urinary bladder and designated five regions: the (1) Apex, (2) Apex-Mid, (3) Mid, (4) Mid-Base, 
and (5) Base. We then mapped prostate cancer localization on eight zones around the urethra for each of those regions.
Results: Prostate cancer was detected in 93 cases of 121 cases (76.9%) in the Apex, in 115 cases (95.0%) in the Apex-Mid, in 101 cases 
(83.5%) in the Mid, in 71 cases (58.7%) in the Mid-Base, and in 23 cases (19.0%) in the Base. In 99.2% of all cases, prostate cancers were 
detected from the Apex to Mid regions. For this reason, transperineal prostate biopsies have routinely been prioritized in the Apex, 
Apex-Mid, and Mid regions, while the Base region of the prostate was considered to be of lesser importance. Our analyses of prostate 
cancer localization revealed a higher rate of cancer in the posterior portion of the Apex, antero-medial and postero-medial portion of 
the Apex-Mid and antero-medial and postero-lateral portion of the Mid. The transperineal prostate biopsies in our institute performed 
had a sensitivity of 70.9%, a specificity of 96.6%, a positive predictive value (PPV) of 92.2% and a negative predictive value (NPV) of 
85.5%.
Conclusions: The concordance of prostate cancer between prostatectomy specimens and biopsies is comparatively favorable. 
According to our study, the diagnostic accuracy of transperineal prostate biopsy can be improved in our institute by including the 
anterior portion of the Apex-Mid and Mid regions in the 12-core biopsy or 16-core biopsy, such that a 4-core biopsy of the anterior 
portion is included.
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INTRODUCTION
Systematic transrectal biopsy was first introduced by Hodge 
et al. [1] in 1989, with numerous modifications and adjust-
ments to the procedure subsequently suggested [2,3]. Re-
cently, 10- to 12-core extended prostate biopsies have super-
seded the sextant biopsy, with greater than 12-core reportedly 
failing to show any significant increase in cancer detection 
rate [4,5]. McNeal et al. [6] reported that 68% of all prostate 
cancers which they detected was localized in the peripheral 
zone (PZ), 24% in the transition zone (TZ), and 8% in the 
central zone. The localization of prostate cancer is known to 
be different in Japanese patients than in those from Western 
countries, with a greater tendency for detection in the Apex 
region in Japan [7-10]. We undertook the current study to 
improve the diagnostic efficiency of transperineal prostate bi-




capsule, and performing biopsies in the Apex, Apex–Mid, 
and Mid regions (Fig. 2). Fig. 3 shows the methods of 12-core 
transperineal biopsies in our institute. Eight-core biopsy sam-
ples are taken from the PZ in ①–④, ⑦–⑩ and 4-core biopsy 
samples are taken from TZ in ⑤, ⑥, ⑪, and ⑫. Repeat biop-
sies included a supplementary 4 cores in the anterior portion 
(⑬–⑯) for a total of 16 cores. Although the size and shape 
of each prostate gland differs from one patient to another, a 
three-dimensional (transverse, lateral, and front) view of a 
transperineal prostate biopsy suggests that it is difficult to get 
samples from the far-lateral region of the Apex in PZ (① and 
⑦) and the samples of ① and ② are taken from the Apex-
Mid, Mid, and Mid-Base regions. Samples of ②, ③, ⑤, ⑧
, ⑨, and ⑪ are taken from a portion of the Apex to the Mid-
Base regions, while those of ④, ⑥, ⑩, and ⑫ are taken from 
the Apex to the Mid regions. Samples of the anterior portion 
including ⑬, ⑭, ⑮, and ⑯ are taken from the Apex to the 
Mid regions, with slightly upward inclination of the ultra-
sound probe and biopsy needle to avoid penetrating the pubic 
bones. For this reason, we conclude that when the prostate is 
enlarged, we would be unable to get biopsy specimens from 
the Base region in our institute. Fig. 4 shows the mapping of 
cancer locations and biopsy sites in each patient. A total 1,348 
cores from biopsies from 110 patients were mapped onto 
each region and the concordance of prostate cancer in speci-
mens obtained from prostatectomy and biopsy were used in 
the calculation of sensitivity, specificity, PPV, and NPV.
opsies performed in Juntendo University Nerima Hospital by 
analyzing specimens from radical prostatectomies in order to 
determine the precise localization of prostate cancer.
MATERIALS AND METHODS
1. Materials
We analyzed radical prostatectomy specimens of 121 patients 
from Juntendo University Nerima Hospital in the period from 
April 2007 to December 2012. All patients underwent open 
radical prostatectomy and had preoperative clinical staging 
of cT2 or under, while none underwent pretreatment such as 
transurethral resection of the prostate or neoadjuvant hor-
monal therapy. The patients ranged from 53 to 78 years old, 
with an average and median age of 67.6 and 68 years, respec-
tively. PSA level at the time of diagnosis ranged from 1.2–32.5 
ng/mL, with an average of 8.9 ng/mL and a median level of 7.9 
ng/mL. The preoperative clinical stage was cT1 in 37 patients 
and cT2 in 84 patients. Gleason score (GS) of prostate biop-
sies were as follows: GS ≤6, 41 cases (35.7%); GS =7, 46 cases 
(40.0%); GS ≥8, 28 cases (24.3%). GS of prostatectomies were 
as follows: GS ≤6, 31 cases (27.0%); GS =7, 62 cases (53.9%); 
GS ≥8, 22 cases (19.1%). The pathological stages were as fol-
lows: pT2a, 27 cases (22.3%); pT2b, 1 case (0.8%); pT2c, 58 cas-
es (48.0%); pT3a, 28 cases (23.1%); and pT3b, 7 cases (5.8%).
2. Methods
The specimens from radical prostatectomy were fixed in 
formalin, after which sections were step-sectioned at 5-mm 
intervals. As shown in Fig. 1, the prostate was divided into five 
regions from the Apex of the urethra to the Base of the urinary 
bladder, centered around the Mid region, with designations 
as follows: A, Apex; A–M, Apex–Mid; M, Mid; M–B, Mid–Base; 
and B, Base. Each region was then divided into eight zones 
around the urethra, with each region further designated as: 
E, antero–lateral; F, antero–medial; G, postero–lateral; and 
H, postero–medial. The transperineal prostate biopsies were 
performed utilizing ultrasonography equipment (Toshiba 
Medical Systems Co., Otawara, Japan), using a 7.0-MHz bi-
plane transrectal probe (PVL-715RT) and a BARD MAGNUM 
(C.R. Bard Inc., Covington, GA, USA) biopsy needle with 22-
mm penetration length. The probe was equipped with an 
adapter (UAGL-001AHA Toshiba Medical Systems Co.) for 
the biopsy needle running parallel to the probe. In Japanese 
patients with prostate cancer, the cancer has been reported 
to localize at a higher frequency in the Apex as compared to 
patients from Western countries [8,9]. Therefore, we inserted 
the biopsy needle transperineally, penetrating the prostate 
Fig. 1. Five regions from the Apex to the Base and eight zones 
around the urethra with each region. E, antero–lateral; F, antero–
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gions, 95.5% was detected in the Apex–Mid and Mid regions, 
and 84.3% was detected in the Mid and Mid–Base regions 
(Table 1). The  frequency of cases where the cancer was de-
tected only in one region was low. Prostate cancer in the Apex 
alone was detected only in 4 cases (3.3%), there were 6 cases 
(5.0%) detected in the Apex-Mid region alone, and there were 
RESULTS
As shown in Fig. 4, a total of 121 prostate cancer specimens 
were each divided into 5 regions for cancer mapping. Out 
of the 121 cases, 93 cases (76.9%) were found to be localized 
in the Apex, 115 cases (95.0%) in the Apex–Mid, 101 cases 
(83.5%) in the Mid, 71 cases (58.7%) in the Mid–Base, and 23 
cases (19.0%) in the Base. Ninety-nine point two percent of 
all cancer cases were detected in the Apex and Apex–Mid re-
Fig. 2. (A) Ultrasound probe and adapter, (B-D) transperineal prostate biopsy.
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Fig. 3. Transperineal prostate biopsy: transverse view, lateral 
view, and front view.
Transverse view















































Fig. 4. Transverse view: prostate cancer localization and trans-
perineal prostate biopsy.




no cases where cancer was detected in the Mid, Mid–Base, or 
Base alone. In 16 cases (13.2%), cancer was detected in all re-
gions from the Apex to the Base.
 The frequency of prostate cancer cases in the eight zones 
in E, F, G, and H is shown in Table 2. In the Apex samples, the 
frequency of cancer in the posterior area of G and H regions 
was high at 45.9% and 41.0%, respectively. In Apex–Mid 
samples, the frequency was also high at 52.0% in the antero-
medial area designated as F, while slightly lower frequencies 
of 30%–40% occurred in regions E, G, and H. In Mid sample, 
cancer was detected fairly uniformly throughout, but was es-
pecially frequent in the antero-medial portion F (45.9%) and 
the postero-lateral portion G (41.8%). In the Mid–Base, can-
cer was detected in the antero-medial portion F in 27.0% of 
cases; cancer was detected in 20% of cases or less elsewhere. 
In the Base, the frequency of cancer occurrence was low and 
constituted less than 10% of regions in which cancer was de-
tected at all.
 The concordance of prostate cancer in prostatectomy speci-
mens and biopsy sites was analyzed and the resultant sen-
sitivity, specificity, PPV, and NPV are as follows. Three hun-
dred and seventy-three biopsy cores were positive out of a 
total of 1,348 cores, and negative in the remaining 975 cores. 
There were 65 cases in which one to three cores were posi-
tive (59.1%), 35 cases in which four to six cores were positive 
(31.8%), and 10 cases in which seven to twelve cores were 
positive (9.1%). In our institute, the transperineal prostate bi-
opsy resulted in 29 cores showing false positive results (2.2%), 
and 141 cores showing false negative results (10.5%), giving 
rise to a sensitivity of 70.9% and a specificity of 96.6%. The PPV 
was 92.2%, while the NPV was 85.5% (Table 3). The average 
prostate volume was 37.0 mL and median volume was 32.8 
mL, which were calculated based on 76 cases. We did not find 
a relationship between prostate volume and accuracy of pros-
tate biopsy.
DISCUSSION
A disparity of prostate cancer localization in radical prosta-
tectomy is recognized between Japanese patients and those 
of Western countries. Iremashvili et al. [7] reported a 65.4% 
cancer detection rate in the Apex, a 56.6% detection rate in 
the Mid, and a 46.3% detection rate in the Base. Ishii et al. [8] 
reported that at Baylor University and Memorial Sloan Ket-
tering Cancer Center, cancer was detected at the highest rate 
in the Mid at 58%, followed by the Apex at 36%, and lastly 
in the Base at 6%. In this study, Apex carcinomas showed a 
lower tendency for extracapsular extension than Mid or Base 
carcinomas (27% vs. 43% and 52%, respectively), as well as 
lower tendencies for seminal vesicle involvement (5% vs. 13% 
and 20%, respectively). In contrast, Takashima et al. [9] and 
Sazuka et al. [10] reported that a high proportion of prostate 
cancers in Japan was detected in the Apex (82.3% and 85%, 
respectively) that was comparable with the detection rates in 
the Mid (85.5% and 77%, respectively), and lowest in the Base 
(48.4% and 22%, respectively). Takahashi et al. [11] reported a 
higher incidence of cancer in Japan than in the United States 
in the TZ zone, in which the induration was not palpable by 
Table 1. Prostate cancer localization in the Apex, Apex–Mid, 
Mid, Mid–Base, and Base out of the 121 cases






Ninety-nine point two percent of all cancer cases were detected in the 
Apex and Apex–Mid regions, 95.5% was detected in the Apex–Mid and 
Mid regions, and 84.3% was detected in the Mid and Mid–Base regions.
Table 2. The proportion of cancer localization in each region
Region
Frequency of prostate cancer cases (%)
E F G H
Apex 15.6 22.1 45.9 41.0  
Apex–Mid 30.0 52.0 38.1 42.2  
Mid 31.6 45.9 41.8 37.3  
Mid–Base 18.9 27.0 18.0 20.1  




















Table 3. Concordance of prostate cancer in prostatectomy 
specimen and biopsy 
Prostate cancer (+) Prostate cancer (–) Total
Biopsy (+) 344a) 29b) 373
Biopsy (–) 141c) 834d) 975
Total 485 863 1,348
Sensitivity (=TP/[TP+FN]), 70.9%; specificity (=TN/[FP+TN]), 96.6%; 
positive predictive value ( =TP/[TP+FP]), 92.2%; negative predictive 
value (=TN/[TN+FN]), 85.5%.
a)True positive (TP). b)False positive (FP). c)False negative (FN). d)True neg-
ative (TN).




digital rectal examination. Analysis in our institute based on 
the five regions yielded a cancer detection rate of 76.9% in 
the Apex, 95% in the Apex–Mid, 83.5% in the Mid, 58.7% in 
the Mid–Base, and 19% in the Base. Ninety-nine point two 
percent of all cancer cases were detected in the Apex and 
Apex–Mid regions, 95.5% was detected in the Apex-Mid and 
Mid regions, and 84.3% was detected in the Mid and Mid-
Base regions (Table 1). Our analysis, like that of others in 
Japan, found a high incidence of prostate cancer that could 
be detected in the Apex. We also found that prostate cancer 
was generally not limited to only one of the five regions, with 
detection rates in the Apex or Apex-Mid region alone being 
under 5%, and no case having cancer detected in the Mid, 
Mid-Base or Base region alone. Although all patients had pre-
operative disease staging of T2 or under, cancer was detected 
in all 5 regions in 16 patients (13.2%).
 Table 2 shows the proportion of cancer localization in each 
region. In the Apex, cancer most often localized to the poste-
rior portion, while in the Apex-Mid, localization tended to be 
high in the antero-medial portion. In the Mid, cancer local-
ization tended to be highly frequent in the antero-medial and 
postero-lateral portions. In the Mid-Base, cancer localization 
tended to the antero-medial portion, with 20% or less detec-
tion elsewhere. Cancer showed low frequency in the Base, 
with a detection rate of 10% or lower in all areas.
 In most institutions in United State, transrectal prostate 
biopsies are performed, whereas transperineal prostate bi-
opsies are performed at some institutes in Japan and Europe. 
Kakehi et al. [12] conducted a nationwide survey in Japan, 
reporting that 76% of biopsies were transrectal, 23% were 
transperineal, and 1% involved a combined method, with the 
frequency of complications of biopsies such as fever and sep-
sis reported as significantly lower in the transperineal biop-
sies. Emiliozzi et al. [13] conducted 6-core transperineal and 
6-core transrectal biopsies on 107 patients, with prostate can-
cer detected in 43 patients (40%); the transperineal approach 
yielded 38% (41/107) detection, whereas the transrectal ap-
proach yielded 32% (34/107), resulting in a higher detection 
rate with the transperineal approach. However, as there was 
no information on the biopsy site, this report could not dis-
criminate between the accuracy of prostate biopsies using the 
transrectal and transperineal approaches. Of interest to note, 
despite the report of a high detection rate of cancer in the 
Apex in Japan by Sazuka et al. [10], transrectal prostate biop-
sies often result in a false negative for cancer in the Apex, with 
transperineal prostate biopsy or other precise imaging being 
reportedly required for detection.
 The current study sought to improve the diagnostic accura-
cy of transperineal prostate biopsy by comparing specimens 
taken from radical prostatectomies and prostate biopsies. 
In our method, we utilize an 18-G biopsy needle with BARD 
MAGNUM reusable core biopsy instrument of 22-mm-long 
tissue core that is guided by transrectal ultrasound (TRUS). 
Therefore, a tissue collection spanning all regions from Apex 
to Base cannot normally be achieved with a single biopsy, ex-
cluding cases with a small prostate gland. In consideration of 
studies reporting a high rate of cancer detection in the Apex 
in Japan [9,10], we have performed transperineal prostate 
biopsies primarily in the Apex, Apex–Mid, and Mid regions by 
inserting the biopsy needle transperineally to penetrate the 
prostate membrane (Fig. 2). As the cancer is rarely detected 
in the Base region alone, we considered it unnecessary to 
perform additional biopsies in the Mid–Base to the Base re-
gions at an initial or routine transperineal prostate biopsy for 
the purpose of improving cancer detection rates. However, 
it is necessary to perform a repeat biopsy of the Mid–Base, 
Base and seminal vesicle for a pathological investigation of 
seminal vesicle involvement. Schulte et al. [14] reported that 
the concordance rate of prostatectomy specimens and needle 
biopsy specimens in a 12-core or more extended biopsies 
using a template resulted in a PPV of 97.3% in the right lobe 
and 96.7% in the left lobe, with a lower rate in NPV of 24.7% 
in the right lobe and 31.3% in the left. Huo et al. [15] reported 
the overall sensitivity of 48% and specificity of 84.1% in a sys-
tematic template guided transperineal biopsy and greatest 
accuracy in the postero-lateral zone. Sensitivity was 59.9%, 
with the lowest being reported in the anterior apex (38.8%) 
and lateral zone (41.2%). Rogatsch et al. [16] reported a PPV 
of 71.1%, a NPV of 75.5%, and a sensitivity of 44.5%, with a 
positive apical margin and apical tumor involvement at the 
Apex difficult to estimate through biopsy. Sazuka et al. [10] 
performed 14-core transrectal prostate biopsies of a 17-mm-
long tissue. They performed 12-core biopsies from the PZ and 
the remaining 2 cores from the TZ. In radical prostatectomy 
specimens, they detected cancer in the Apex (85%), Middle 
(75%), Base (22%), and TZ (22%); when they further exam-
ined anterior vs. posterior portions in each region, however, 
they detected cancer at rates of 77%, 53%, 13%, and 16%, 
respectively, in the anterior, and at 49%, 51%, 13%, and 11%, 
respectively, in the posterior, with localization in the anterior 
apex (77%) showing the highest frequency. Analysis of the 
concordance between radical prostatectomy specimens and 
the transrectal prostate biopsies revealed 51% true positive, 
49% false negative, 17% false positive, and 83% true negative 
results. The analysis in our institute revealed a false positive 
in 29 cores (2.2%), a false negative in 141 cores (10.5%), 70.9% 




sensitivity, and 96.6% specificity, with a 92.2% PPV and 85.5% 
NPV, showing comparatively favorable results. There were 
65 cases in which one to three cores were positive (59.1%), 
35 cases in which four to six cores were positive (31.8%), and 
10 cases in which seven to twelve cores were positive (9.1%). 
These results suggest that the prostate cancers were fairly 
wide spread in our specimens, although the actual tumor 
volume could not be calculated. We consider that these facts 
make some contributions to the diagnostic accuracy of pros-
tate biopsy.
 As shown in Fig. 4, initial transperineal prostate biopsies in 
our institute were performed at 12 sites (①–⑫); repeat biop-
sies were performed at an additional 2 sites bilaterally of the 
anterior portion (a 16-core biopsy in total), in consideration 
of the fact that cancer often localizes in the anterior portion. 
Transperineal prostate biopsies require a three-dimensional 
consideration of the prostate. The tissue collection site will 
vary depending on the method used to insert the biopsy nee-
dle. In order to use a probe adapter, we inserted the needle to 
run parallel with the probe. As the shape and size of the pros-
tate gland varies from person to person, each patient must be 
considered individually; since accessing the far lateral PZ (① 
and ⑦) through the Apex region is difficult, we performed tis-
sue collection primarily in the Apex–Mid, Mid and Mid–Base 
regions. Tissue collections for ②, ③, ⑤, ⑧, ⑨, and ⑪ were 
performed from part of the Apex through part of the Mid–
Base, for ④, ⑥, ⑩, and ⑫ from the Apex through the Mid, and 
for the anterior portions of ⑬, ⑭, ⑮, and ⑯ from the Apex 
through the Mid, with the tip of the ultrasound probe tilted 
upward to avoid penetrating the pubis. In contrast, the Apex 
is accessible from almost any point when tissue collection is 
performed similar to a radial or shotgun style biopsy method 
from the perineum. However, due to the difficulty of this tech-
nique, we do not utilize this method. In Japan, most prostate 
cancer cases are localized in the Apex, Apex–Mid, and Mid, 
hence when a biopsy needle with a 22-mm-long is utilized, a 
tissue collection around the region of the prostate membrane 
facilitates sampling of the Apex, Apex–Mid, and Mid.
 Table 2 illustrates the sites showing the greatest predilec-
tion for cancer in each region, and these are comparable to 
biopsy sites from our institute shown in ②–④ and ⑧–⑩. In 
the Apex, these are the posterior G (45.9%) and H (41.0%). In 
the Apex–Mid region, cancer was often localized in antero-me-
dial F (52.0%), corresponding to ⑥, ⑫, ⑬, ⑭, ⑮, and ⑯. H 
showed a slightly lower rate at 42.2%, corresponding to ③, ④, 
⑨, and ⑩. Cancer localization was fairly uniform in the Mid, 
clustering somewhat in the antero-medial F (45.9%), which 
corresponds to ⑥, ⑫, ⑬, ⑭, ⑮, and ⑯, the and postero-
lateral G (41.8%), corresponding to ①, ②, ⑦, and ⑧.
 Analysis of prostate cancer localization shows that, to in-
crease the diagnostic accuracy of the transperineal biopsies, 
these biopsies: (1) should be performed in the Apex, Apex–
Mid, and Mid; (2) need not include the Base when performed 
routinely; (3) should include the antero-medial area when 
performed in the Apex; (4) should include the antero-medial 
and postero-lateral areas when performed in the Apex-Mid; 
and (5) should include the antero-medial and postero-lateral 
areas in the Mid, as these areas tend to correlate with a higher 
detection rate of cancer.
 There is no statistically significant difference between the 
cancer detection rate of transrectal and transperineal prostate 
biopsies, but in the sextant biopsies there is a improvement of 
cancer detection rate to add biopsy sites corresponding to the 
anterior apical region [17] and lateral region [18]. Takenaka 
et al. [19] performed a prospective comparison of 6- and 12-
core transperineal prostate biopsies and reported a statisti-
cally significant difference, with the 12-core biopsies yielding 
a higher cancer detection rate. Merrick et al. [20] performed 
transperineal template-guided saturation biopsies on 24 sites. 
Cancer was most often detected in the ventral area of the 
Apex, but no statistically significant difference was reported. 
Transperineal prostate biopsy performed on 12 or more cores 
is usually performed with alternative forms of anesthesia oth-
er than local anesthesia. In our institute 12-core transperineal 
prostate biopsies are carried out under general anesthesia 
except for advanced cases. We have safely performed approx-
imately 900 transperineal prostate biopsies, without fever, 
septicemia, or other complications among the patients. Ac-
cording to our study, the diagnostic accuracy of transperineal 
prostate biopsy can be improved in our institute by including 
the anterior portion of the Apex–Mid and Mid regions in the 
12-core biopsy or 16-core biopsy, such that a 4-core biopsy of 
the anterior portion is included. 
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